Crown Bioscience Expands CVMD Leadership Team

SANTA CLARA, Calif., Aug. 25, 2016 /PRNewswire/ — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of Amar Thyagarajan, Ph.D., and Sandeep Sinha, Ph.D., to its team.Crown Bioscience Inc. LogoMoreThyagarajan joins CrownBio as the associate director of product marketing and strategy. With extensive experience in bringing new products to market, he is responsible for the strategic and scientific marketing of CrownBio’s cardiovascular and metabolic disease (CVMD) portfolio.Thyagarajan brings extensive scientific and senior product management experience with genetically engineered models used in neuroscience and CVMD drug discovery and safety and toxicology studies. He earned his doctorate in neuroscience at the State University of New York at Albany, followed by a postdoctoral fellowship at the Massachusetts Institute of…

Link to Full Article: Crown Bioscience Expands CVMD Leadership Team

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!